Please read our privacy notice for more information on the cookies we use and how to delete or block the use of cookies.Takeda has no influence or control over the content of this third party website. All rights reserved The site uses cookies to provide you with a more responsive and personalized service. When considering pharmacological treatment, the guidelines recommend initial medication with stimulants for ADHD with comorbid antisocial personality disorder, tic disorder (alternatively atomoxetine or guanfacine) and anxiety disorders (alternatively atomoxetine); where there is an increased risk of improper use of stimulant medication, long-acting formulations should be considered.The 2018 German guidelines for ADHD emphasise the multimodal management of ADHD in children, adolescents and adults, ensuring that both the severity of the disorder and patient/caregiver preferences are taken into account. Evidence-based and consensus-driven guidelines for the treatment of ADHD help consolidate practice InternationallyEvidence-based or consensus-driven guidelines for the treatment of attention-deficit hyperactivity disorder (ADHD), or hyperkinetic disorder (HKD), have become an important framework for consolidating practice across countries and helping to improve the quality of care.A number of clinical guidelines for the management of ADHD have been developed over the years (There are multiple guidelines available to guide clinicians working in the field of ADHD in children, adolescents and adults, and different guidelines may also have different recommendations about specific treatment approaches.The NICE guidelines were updated in 2018 and stipulate that children, adolescents and adults with ADHD require a comprehensive, holistic, shared treatment plan that addresses a wide range of personal, social, educational and occupational needs, and that this care should be provided by healthcare professionals with training and expertise in diagnosing and managing ADHD.The CADDRA guidelines for the management of children, adolescents and adults with ADHD were updated in March 2018, and recommend a comprehensive, collaborative and multimodal treatment approach to ADHD.The CADDRA core principle for the effective treatment of ADHD states that: Updated German guidelines covering the diagnosis and management of ADHD in children, adolescents and adults were released in June 2018.
The guidelines, developed by a diverse group of healthcare professionals comprising different specialities and societies involved in the treatment of patients with ADHD, are described as a set of recommendations based on a systematic review of available evidence and a benefit/risk evaluation of treatment alternatives, with the aim of optimising healthcare for patients.The current clinical practice guidelines focus on providing a therapeutic approach to the management of ADHD that takes into account psychological, psychosocial, psychoeducational and pharmacological interventions. S3-Leitlinie ADHS bei Kindern, Jugendlichen und Erwachsenen (2018) Federführung: DGPPN, Deutsche Gesellschaft für Kinder- und Jugendpsychiatrie, Psychosomatik und Psychotherapie (DGKJP), Deutsche Gesellschaft für Sozialpädiatrie und Jugendmedizin e. V. (DGSPJ) Die DGKJP überarbeitet ihre Website. The German guidelines emphasise that the treatment of ADHD should be delivered in the context of a multimodal treatment plan, which can combine psychosocial (including psychotherapeutic) and pharmacological and supplementary interventions, according to the individual symptoms, the level of functioning, participation, and the preferences of the patient and their social network.In an effort to consolidate available evidence, the Spanish guidelines for the management of ADHD were developed to promote effective decision-making with a focus on the patient. The recommendations emphasise that treatment should be delivered in the context of a multimodal treatment plan, which can combine psychosocial (including psychotherapeutic) and pharmacological (when appropriate) and supplementary interventions, according to the individual symptoms, the level of functioning, participation, and the preferences of the patient and their social network.Where pharmacological therapy is indicated, it is recommended that it be initiated by a qualified specialist with experience in that specific patient group. Das Leitlinien-Informationssystem der AWMF selbst ist als Datenbankwerk gemäß § 4 UrhG gesondert geschützt. German guidelines update 2018 – ADHD in childhood, adolescence and adulthoodIn June 2018, a new version of the German guidelines for the diagnosis and management of ADHD in childhood, adolescence and adults was released,These guidelines are evidence-based and were developed with consensus of an interdisciplinary team.
In den letzten Jahren wurden Leitlinien zur Diagnosestellung und validierte Fragebögen zu ADHS-Symptomen entwickelt, die die Diagnostik der ADHS im Erwachsenenalter erleichtern.
During diagnosis, if there are signs of comorbid psychiatric disorders, or if a differential diagnosis against other psychiatric disorders is required, it is recommended that the patient is referred to a specialist for diagnosis if needed.